Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study

Eur Respir J. 2022 Feb 3;59(2):2101801. doi: 10.1183/13993003.01801-2021. Print 2022 Feb.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use
  • Humans
  • Pulmonary Embolism* / complications
  • Recurrence
  • Risk Factors
  • Venous Thromboembolism* / complications

Substances

  • Anticoagulants